Archimedes Closes $4.9M Seed Round led by Hack VC
The Archimedes team has raised a total of $7.3M pre-launch fundraising from some of crypto’s most prominent VCs...
Globe Newswire2-02-2023, 00:02
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai 18-09-2024, 22:07